Filing Details
- Accession Number:
- 0000014272-21-000193
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-03 16:50:17
- Reporting Period:
- 2021-07-30
- Accepted Time:
- 2021-08-03 16:50:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1677618 | Rupert Vessey | 430 E. 29Th Street 14Th Floor New York NY 10016 | Evp, Research & Early Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2021-07-30 | 17,740 | $68.01 | 36,650 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 5,843 | $58.78 | 42,493 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 6,305 | $63.41 | 48,798 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 1,651 | $60.53 | 50,449 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 1,454 | $54.20 | 51,903 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 373 | $56.44 | 52,276 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 29,489 | $63.41 | 81,765 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 5,843 | $61.01 | 87,608 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 2,905 | $54.20 | 90,513 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 17,630 | $56.44 | 108,143 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 24,134 | $61.34 | 132,277 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 22,483 | $60.53 | 154,760 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 15,879 | $55.52 | 170,639 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 8,489 | $44.70 | 179,128 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2021-07-30 | 8,489 | $47.81 | 187,617 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2021-07-30 | 140,653 | $68.08 | 46,964 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 5,843 | $0.00 | 5,843 | $58.78 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 6,305 | $0.00 | 6,305 | $63.41 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 1,651 | $0.00 | 1,651 | $60.53 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 1,454 | $0.00 | 1,454 | $54.20 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 373 | $0.00 | 373 | $56.44 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 29,489 | $0.00 | 29,489 | $63.41 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 5,843 | $0.00 | 5,843 | $61.01 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 2,905 | $0.00 | 2,905 | $54.20 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 17,630 | $0.00 | 17,630 | $56.44 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 24,134 | $0.00 | 24,134 | $61.34 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 22,483 | $0.00 | 22,483 | $60.53 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 15,879 | $0.00 | 15,879 | $55.52 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 8,489 | $0.00 | 8,489 | $44.70 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2021-07-30 | 8,489 | $0.00 | 8,489 | $47.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-05-04 | No | 4 | M | Direct | |
| 0 | 2025-02-02 | No | 4 | M | Direct | |
| 0 | 2027-01-30 | No | 4 | M | Direct | |
| 0 | 2026-02-01 | No | 4 | M | Direct | |
| 0 | 2026-05-02 | No | 4 | M | Direct | |
| 0 | 2025-02-02 | No | 4 | M | Direct | |
| 0 | 2025-11-09 | No | 4 | M | Direct | |
| 0 | 2026-02-01 | No | 4 | M | Direct | |
| 0 | 2026-05-02 | No | 4 | M | Direct | |
| 0 | 2026-08-01 | No | 4 | M | Direct | |
| 0 | 2027-01-30 | No | 4 | M | Direct | |
| 3,494 | 2028-01-29 | No | 4 | M | Direct | |
| 8,491 | 2028-05-08 | No | 4 | M | Direct | |
| 8,491 | 2028-07-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 622 | Indirect | BMS Savings and Investment Program |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.93 to $68.045, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- 140,653 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.165, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on a plan statement as of the end of the most recent fiscal quarter.
- All of the shares are currently exercisable.
Billionaire Hedge Funds
